We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Drug Discovery

Stay up to date on the topics that matter to you

ProBioGen AG

We are a Contract Development and Manufacturing Organization (CDMO) and technology provider with extensive expertise in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals.

Latest ProBioGen AG Content

Product News

ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease

ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.

Never miss a story

with the Breaking Science News daily newsletter